investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
The Role of Fgf Signaling in Vertebrate DevelopmentĀ
Mark Lewandoski
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Thomas Schimmang
University of Valladolid
Valladolid, Spain
Mark Lewandoski
National Cancer Institute (NIH)
Rockville, United States
Related projects
Scott M Dehm
AR Gene Rearrangements and AR Signaling in Prostate Cancer
Prostate
Pathology
Radoslav Goldman
Basic Cancer Research in Cancer Health Disparities
Prostate
Pathology
Pilar Blancafort
Targeted Epigenetic Silencing of Oncogenic Transcription Factors (PQ18)
Breast
Philip Tofilon
Radiation-induced translational control of gene expression
Breast
Prostate
Radiation Oncology
Lali K Medina-Kauwe
Tumor Targeted Corroles for Detection and Intervention
Breast
James D Marks
Antibody Research Technology Center
Kidney, renal pelvis and ureter
Khandan Keyomarsi
Targeting the cell cycle in triple negative breast cancer
Breast
Raymond B Birge
Non-canonical signal pathway for Crk in breast cancer
Breast
Hugh S. Gannon
Extraordinary responder cell lines reveal unique targetable genetic dependencies
Breast